Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation
Clinical trial NCT03637556 · COMPLETED
Trial details
- NCT number
- NCT03637556
- Sponsor
- DisperSol Technologies, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2021-06-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.